OTCMKTS:CCEL Cryo-Cell International (CCEL) Stock Forecast, Price & News $5.28 0.00 (0.00%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$5.17▼$5.5050-Day Range$5.03▼$6.3152-Week Range$2.69▼$7.25Volume14,514 shsAverage Volume10,057 shsMarket Capitalization$43.77 millionP/E Ratio18.86Dividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest About Cryo-Cell International (OTCMKTS:CCEL) StockCryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.Read More CCEL Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CCEL Stock News HeadlinesAugust 31, 2023 | benzinga.comCryo-electron Microscopy Market worth $2.1 billion by 2028July 19, 2023 | markets.businessinsider.comMaxim Group Keeps Their Buy Rating on Cryo-Cell International (CCEL)September 27, 2023 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>>July 14, 2023 | finance.yahoo.comCord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial ResultsMay 4, 2023 | marketwatch.comStem Cell Services Market to Receive Overwhelming Hike in Revenues by 2030 With key Players Paragon Bioservices, APEX Biologix, VcanBio, Cryo-cellApril 28, 2023 | marketwatch.comCell Banking Outsourcing Market Research Analysis 2023-2031April 27, 2023 | marketwatch.comGlobal Cord Blood Stem Cells Market by [2023-2029] with Revenue OutsourcingApril 24, 2023 | msn.comLooking Into Cryo-Cell International's Return On Capital EmployedSeptember 27, 2023 | Chaikin Analytics (Ad)This Stock Could Go Up 66% or More.Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.April 21, 2023 | msn.comCPS Technologies CEO resignsApril 21, 2023 | msn.comCRYO-CELL International GAAP EPS of $0.09 beats by $0.13, revenue of $7.82M beats by $0.41MApril 21, 2023 | finance.yahoo.comCord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial ResultsMarch 30, 2023 | marketwatch.com2023-2029 Cord Stem Cell Banking Market Size and Industrial Analysis with Market Dynamics | Latest Report by Absolute ReportsMarch 22, 2023 | marketwatch.comCell Banking Outsourcing Market Outlook by 2031March 1, 2023 | msn.comCRYO-CELL International GAAP EPS of $0.33 beats by $0.20, revenue of $30.3M beats by $0.46MMarch 1, 2023 | finance.yahoo.comCryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022February 22, 2023 | seekingalpha.comCCEL Cryo-Cell International, Inc.February 16, 2023 | marketwatch.comStem Cell Services Market 2028 By Product Type, End User, Capacity and GeographyFebruary 16, 2023 | marketwatch.comCell Banking Outsourcing Market Size, Share and Forecast 2029 with Top Countries DataFebruary 15, 2023 | marketwatch.comHematopoietic Stem Cell Transplantation (HSCT) Market 2023-2029 With Highly Productive Segment To Expand OutstandinglyFebruary 14, 2023 | marketwatch.comCell Banking Outsourcing Market Size 2023 With Presentation Outlook, Horizontal Viewpoint, Global ViewFebruary 13, 2023 | marketwatch.comCell Banking and Storage Market Size, Analysis with Key Players having Regional Statistics and Application Forecast to 2028February 10, 2023 | marketwatch.comUmbilical Cord Blood Banking Market Size Encyclopedic Research Report 2023 which includes Top Key Players, Growth Rate, and Demand Forecast by 2027November 16, 2022 | benzinga.comCryo-Cell International Chairman Trades Company's StockOctober 14, 2022 | finance.yahoo.comCord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial ResultsAugust 22, 2022 | finance.yahoo.comCord Blood Banking Leader Cryo-Cell Announces Special Cash DividendAugust 18, 2022 | seekingalpha.comCryo-Cell International to transfer listing from Nasdaq to NYSESee More Headlines Receive CCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter. Email Address CCEL Company Calendar Last Earnings7/14/2023Today9/26/2023Next Earnings (Estimated)10/12/2023Fiscal Year End11/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CCEL CUSIPN/A CIK862692 Webwww.cryo-cell.com Phone(813) 749-2100Fax813-855-4745Employees80Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.28 Trailing P/E Ratio18.86 Forward P/E RatioN/A P/E GrowthN/ANet Income$2.77 million Net Margins7.38% Pretax Margin9.09% Return on Equity-168.11% Return on Assets3.44% Debt Debt-to-Equity RatioN/A Current Ratio0.52 Quick Ratio0.48 Sales & Book Value Annual Sales$30.34 million Price / Sales1.44 Cash Flow$0.54 per share Price / Cash Flow9.82 Book Value($0.18) per share Price / Book-29.33Miscellaneous Outstanding Shares8,290,000Free Float5,382,000Market Cap$43.77 million OptionableNot Optionable Beta0.33 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. David I. Portnoy (Age 60)Chairman & Co-CEO Comp: $1.07MMr. Mark L. Portnoy (Age 59)Co-CEO & Director Comp: $764kMs. Jill M. Taymans (Age 53)CFO & VP of Fin. Comp: $227.99kMr. Oleg Mikulinsky (Age 50)Chief Information Officer Comp: $360kDr. Joanne Kurtzberg M.D.Medical Director and Member of Medical & Scientific Advisory BoardKey CompetitorsLisata TherapeuticsNASDAQ:LSTAMangoceuticalsNASDAQ:MGRXFortress BiotechNASDAQ:FBIOViracta TherapeuticsNASDAQ:VIRXSonendoNYSE:SONXView All CompetitorsInsidersDavid PortnoyBought 516 shares on 11/17/2022Total: $2,528.40 ($4.90/share)David PortnoyBought 10,000 shares on 11/14/2022Total: $48,000.00 ($4.80/share)David PortnoyBought 3,850 shares on 11/10/2022Total: $18,865.00 ($4.90/share)David PortnoyBought 20,000 shares on 11/8/2022Total: $97,800.00 ($4.89/share)View All Insider Transactions CCEL Stock - Frequently Asked Questions How have CCEL shares performed in 2023? Cryo-Cell International's stock was trading at $4.23 at the start of the year. Since then, CCEL stock has increased by 24.8% and is now trading at $5.28. View the best growth stocks for 2023 here. When is Cryo-Cell International's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, October 12th 2023. View our CCEL earnings forecast. How were Cryo-Cell International's earnings last quarter? Cryo-Cell International, Inc. (OTCMKTS:CCEL) issued its quarterly earnings results on Friday, July, 14th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.10. The business had revenue of $7.77 million for the quarter. Cryo-Cell International had a negative trailing twelve-month return on equity of 168.11% and a net margin of 7.38%. What other stocks do shareholders of Cryo-Cell International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cryo-Cell International investors own include NVIDIA (NVDA), Overstock.com (OSTK), Avid Technology (AVID), Boeing (BA), Enphase Energy (ENPH), OPKO Health (OPK), Riot Platforms (RIOT), Aldeyra Therapeutics (ALDX), Alimera Sciences (ALIM) and Allena Pharmaceuticals (ALNA). What is Cryo-Cell International's stock symbol? Cryo-Cell International trades on the OTCMKTS under the ticker symbol "CCEL." How do I buy shares of Cryo-Cell International? Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cryo-Cell International's stock price today? One share of CCEL stock can currently be purchased for approximately $5.28. How much money does Cryo-Cell International make? Cryo-Cell International (OTCMKTS:CCEL) has a market capitalization of $43.77 million and generates $30.34 million in revenue each year. The company earns $2.77 million in net income (profit) each year or $0.28 on an earnings per share basis. How can I contact Cryo-Cell International? Cryo-Cell International's mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The official website for the company is www.cryo-cell.com. The company can be reached via phone at (813) 749-2100, via email at investors@cryo-cell.com, or via fax at 813-855-4745. This page (OTCMKTS:CCEL) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryo-Cell International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.